Hem
  • 简体中文
  • Hem
  • Vårdpersonal
  • Konsument
  • Om BioGaia
  • Press
  • Investerare
Vårdpersonal
Utskriftsvänlig version Send to friend
  • Increase
  • Decrease
  • Normal

Current Size: 100%

Grundläggande forskning

Nedan listade forskningsrapporter finns endast på engelska och länkarna leder till den engelska versionen av BioGaias webbplats.

Relevant dokumentation:

The Lactobacillus and Bifidobacterium microflora of the human intestine: composition and succession.
Occurrence of L.reuteri in human breast milk.
An evaluation of probiotic effects in the human gut: microbial aspects. Final Technical report for Food Standards Agency (FSA) project ref G01022
Validation of the probiotic concept: L. reuteri confers broadspectrum protection against disease in humans and animals
Enhancement of human health with L. reuteri
Polyfunctional activities expressed by Lactobacillus reuteri
Commensal-derived probiotics as anti-inflammatory agents
Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution.
The antimicrobial compound reuterin (3-hydroxypropionaldehyde) induces oxidative stress via interaction with thiol groups.

 

  • Kliniska studier
  • Vetenskapliga kongresser
  • Grundläggande forskning
  • Produktkvalitet och leveranssystem
  • BioGaia Probiotiska produkter
KONTAKTSIDA
ANVÄNDARVILKOR I COOKIES
BUSINESS & PARTNER
Lotta Johansson
 
FORSKNING
Eamonn Connolly
 
PRESS
Peter Rothschild
 
INVESTERARE
Margareta Hagman